The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials. On Dec. 13, 2016, Vetter announced that its new clinical syringe line has ...

SKOKIE, Ill.--(BUSINESS WIRE)--Vetter, a leading international contract development and manufacturing organization (CDMO) that specializes in aseptic filling for its (bio-)pharmaceutical customers, ...

Schott Pharmaceuticals is adding a ready-to-fill syringe line at its plant in South Lebanon Township, PA. It's Schott's first manufacturing site for the syringes in the U.S., according to a press ...

Container and equipment innovations expand applications. Prefilled syringes continue to evolve to enhance operation, support increased automation of the fill/finish line, and boost productivity and ...

LEVERKUSEN, Germany, Nov. 13, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it ...

The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile ...

WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...

Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations.